Blog
MDR introduction on May 26, 2021 – is your company prepared?
MDR is coming on May 26, 2021. For Swiss Medtech Companies this also means a decision whether or not to prepare for a set-up with an European Representative (EAR) or not. Swiss Medtech has issued related guidance. Contact MedtechVault to find out how we can help your company to get ready for MDR.
Virtual Audits in Medtech – a Call for Action
In a recent Webinar, the role of virtual audits was assessed. Virtual or remote audits are currently one of the most relevant topics within the Medical Device Industry, especially in times of the corona pandemic (86,4 % of the companies surveyed confirm this relevance). As a result of a virtual panel discussion held with approximately ~150 participants and an accompanying survey, a common position that reflects the medical technology industry standpoint on this topic has been developed. Data...
Checklist for a Secure Remote Audit
Recommended measures for your video conferencing system Use a registered account (not a free service) Make sure of latest software version Protect all meetings with a password Chose a service with a “waiting room” option, check-in all participants prior to start & banish intruders After start block meeting to prevent further access Restrict access rights to protect screen sharing against misuse Requirements for secure document / information exchange Use a system with an easy to use...
MDR introduction postponed to May 26, 2021
(Swiss Medtech) On 17 April 2020, the EU Parliament adopted a proposal to postpone the date of application of the Medical Devices Regulation (MDR) by one year to the 26 May 2021. The regulation shall enter into force on the day of its publication in the Official Journal of the European Union. The postponement entails consequences also for the Swiss medical technology industry. More
Remote Audits allowed by EU Commission
See MDCG guidance how notified bodies can run audits while quarantine / travel restrictions prohibit site visits. The document clearly points out to use "the most advanced available Information and Communication Technologies as appropriate in accordance with legislation on information security and data protection". MedtechVault is the ideal tool for secure data & information exchange during Remote Audits.
Remote Audits for Medical Device Manufacturers: protect your sensitive Data & Trade Secrets!
Medical device manufacturers must grant access of highly sensitive data and information to Notified Bodies during Remote Audits. Although such information is never meant to leave the manufacturer’s site it is often shared via common cloud services, especially in times of travel restrictions. How can transfer of sensitive information be established to securely conduct a Remote Audit? by Arik Zucker (az) · In times of travel restrictions due to the recent COVID-19 outbreak, Notified Bodies have...
MDR introduction delayed in the light of the COVID-19 pandemic?
German medtech trade group BVMed called for a postponement until the end of the coronavirus crisis, pointing to the effect of the outbreak on already stretched notified bodies to make its case. And one day earlier, EU notified body association Team NB warned the “outbreak is having an impact on the implementation of both [MDR and IVDR] due to travel restrictions.”
Need help with your European Authorized Representative?
How do you secure your sensitive & confidential Technical Documentation while giving it out of hands, e.g. to your European Authorized Representative? Here’s the solution: MedtechVault is a highly secure platform to make your Technical Documentation available to your Authorized Representative (AR) and other Economic Operators while providing best possible protection. Also, it enables proven efficiency gain – not only when dealing with your AR! Plus, it’s MDR compliant!
Accelerating the Conformity Assessment process
Curious about how MedtechVault can help accelerating your Conformity Assessment process? Read a blog from Aligned AG for an article that also points out how to deal with the tricky OEM / Legal Manufacturer relationship under MDR! Link to article.
MedtechVault at the MDR Support Panel Event in Berne
The MDR Support Panel provided some insights on the implementation of MDR with a special emphasis on the technical documentation with presentations by Bassil Akra (TÜV SÜD), Michael Maier (Medidee) and Arik Zucker (MedtechVault). Link to event page.
MDR – 4-year transitional period for certain Class I devices
The EU Parliament officially accepted the 2nd MDR corrigendum. As no request for a vote had been made on Tuesday 17 December, the text was deemed adopted. This concerns Class I products that were self-certified under MDD but now need Notified Body certification under MDR. Hence, the following Class I products that obtained MDD declaration of conformity prior to May 26, 2020 will get a 4-year transitional period until 2024: - Reusable surgical Instruments (scissors, forceps, scalpels,...) -...
Four-year transitional period until 2024
MDR: some Class I medical devices will get a four-year transitional period until 2024 as per 2nd Corrigendum issued by European Council. The Corrigendum on MDR (Nov. 25, 2019) states: "By way of derogation from Article 5 of this Regulation, a device which is a class I device pursuant to Directive93/42/EEC, for which the declaration of conformity was drawn up prior to 26 May 2020 and for which the conformity assessment procedure pursuant to this Regulation requires the involvement of a notified...
Update by Swiss Medtech regarding the MRA
From Swiss Medtech: The Medical Device Regulation (MDR) comes into effect in less than half a year. Legal uncertainty regarding the status of Swiss medical devices after 26 May 2020 remains extremely high. It is therefore essential that you consider the current state of affairs when planning your business strategy: Update regarding the Institutional Agreement and the Mutual Recognition Agreement (MRA).
OEM business model under MDR – proposal for solution
The Johner Institute recently published an article about the OEM business model under MDR. A solution where an intermediary would provide a repository of the documentation was suggested. See the full article in their blog.
Implementation of Eudamed for MDR delayed by 2 years
The European Commission has confirmed that the introduction of Eudamed for MDR will be delayed by 2 years to May 2022 and will be done together with the Eudamed introduction for IVDR. It should be noted that it will not affect the MDR implementation deadline. See news for more details. Link to EUDAMED.